Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov 20;456(7220):350-6.
doi: 10.1038/nature07413.

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

Vikas Chandra  1 , Pengxiang Huang, Yoshitomo Hamuro, Srilatha Raghuram, Yongjun Wang, Thomas P Burris, Fraydoon Rastinejad
Affiliations

Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

Vikas Chandra et al. Nature. .

Abstract

Nuclear receptors are multi-domain transcription factors that bind to DNA elements from which they regulate gene expression. The peroxisome proliferator-activated receptors (PPARs) form heterodimers with the retinoid X receptor (RXR), and PPAR-gamma has been intensively studied as a drug target because of its link to insulin sensitization. Previous structural studies have focused on isolated DNA or ligand-binding segments, with no demonstration of how multiple domains cooperate to modulate receptor properties. Here we present structures of intact PPAR-gamma and RXR-alpha as a heterodimer bound to DNA, ligands and coactivator peptides. PPAR-gamma and RXR-alpha form a non-symmetric complex, allowing the ligand-binding domain (LBD) of PPAR-gamma to contact multiple domains in both proteins. Three interfaces link PPAR-gamma and RXR-alpha, including some that are DNA dependent. The PPAR-gamma LBD cooperates with both DNA-binding domains (DBDs) to enhance response-element binding. The A/B segments are highly dynamic, lacking folded substructures despite their gene-activation properties.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overall structure of the PPAR-γ–RXR-α complex on PPRE
a, b, Orthogonal views are shown in which RXR-α is blue and PPAR-γ is red. The ligands rosliglitazone and 9-cis-retinoic acid are shown in green, the Zn(II) ions are white, and the coactivator LXXLL peptides are in light blue and purple.
Figure 2
Figure 2. DNA-binding features of the complex
a, The sequence of PPRE element containing direct repeats of the canonical AGGTCA half-site separated by one base pair (DR1) together with the upstream sequence AAACT specificity element. b, The DBDs and their C-terminal extensions are shown for PPAR-γ (red) and RXR-α (blue). These domains form a polar, DNA-dependent head-to-tail interaction through side chains that converge over the spacer element.
Figure 3
Figure 3. Domain–domain interactions involving the PPAR-γ LBD
a, The PPAR-γ LBD is closely positioned to the PPAR-γ DBD. b, The PPAR-γ LBD (red) interfaces with both receptor DBDs to enhance their DNA association. RXR DBD is in blue. c, The LBD and DBD of RXR-α, do not interact. d, PPAR-γ LBD bisects both RXR-α domains. The proximity of the PPAR-γ ligand to both RXR-α domains can be seen. e, The side-chain interactions between PPAR-γ LBD and RXR-α DBD in the rosiglitazone complex. The PPAR-γ LBD residue Phe 347 lies at the centre of the interface.
Figure 4
Figure 4. Effect of different ligands on the PPAR-γ–RXR-α complex
a, Electron density (Fo −-Fc) omit maps around the PPAR-γ ligands rosiglitazone, BVT.13 and GW9662 from the their respective complexes. b, The three PPAR-γ ligands as a group occupy distinct portions of the receptor’s Y-shaped pocket. c, Comparison of the binding mode of rosiglitazone with GW9662 within the PPAR-γ pocket. GW9662 does not form a covalent bond with Cys 285. d, Superposition of crystal structures obtained with the different PPAR-γ ligands showing minor variations in overall domain organization. The colours are indicated for each complex.
Figure 5
Figure 5. The dynamic features of the receptors
H/D-Ex data for intact PPAR-γ. From top, in a ligand-free state, with rosiglitazone, with GW9662, and with all of rosiglitazone, RXR-α, 9-cis-retinoic acid and PPRE DNA (RXR, etc.). Each horizontal colour block represents an analysed peptic fragment. The deuteration level of each peptide at each time point is colour-coded as in the insert. Each block contains five time points (from top, 15, 50, 150, 500, and 1,500 s).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nagy L, Schwabe JW. Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci. 2004;29:317–324. - PubMed
    1. Sonoda J, Pei L, Evans RM. Nuclear receptors: decoding metabolic disease. FEBS Lett. 2008;582:2–9. - PMC - PubMed
    1. Raghuram S, et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ. Nature Struct Mol Biol. 2007;14:1207–1213. - PMC - PubMed
    1. Yin L, et al. Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways. Science. 2007;318:1786–1789. - PubMed
    1. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT. Nuclear receptor structure: implications for function. Annu Rev Physiol. 2007;69:201–220. - PubMed